| Literature DB >> 15056004 |
Franco Chimenti1, Adriana Bolasco, Fedele Manna, Daniela Secci, Paola Chimenti, Olivia Befani, Paola Turini, Valentina Giovannini, Bruno Mondovì, Roberto Cirilli, Francesco La Torre.
Abstract
A novel series of 1-acetyl-3-(4-hydroxy- and 2,4-dihydroxyphenyl)-5-phenyl-4,5-dihydro-(1H)-pyrazole derivatives 1-12 have been synthesized and investigated for the ability to selectively inhibit the activity of the A and B isoforms of monoamine oxidase (MAO). The new synthesized compounds 1-12 proved to be more reversible, potent, and selective inhibitors of MAO-A than of MAO-B. Knowing that stereochemistry may be an important modulator of biological activity, we performed the semipreparative chromatographic enantioseparation of the most potent, selective, and chiral compounds, 6 and 11. The separated enantiomers were then submitted to in vitro biological evaluation while increasing their inhibitory activity and A selectivity. The (-)-6 enantiomer shows K(i(MAO-A)) = 2 nM and SI = 165 000, (+)-6 shows K(i(MAO-A)) = 6 nM and SI = 166 666, (-)-11 shows K(i(MAO-A)) = 4 nM and SI = 80 000, and (+)-11 shows K(i(MAO-A)) = 7 nM and SI = 38 571.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15056004 DOI: 10.1021/jm031042b
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446